Jundishapur Journal of Microbiology

Published by: Kowsar

Antimicrobial Resistance Patterns and Prevalence of blaPER-1 and blaVEB-1 Genes Among ESBL-producing Pseudomonas aeruginosa Isolates in West of Iran

Mohammad Yousef Alikhani 1 , Zahra Karimi Tabar 1 , Fatemeh Mihani 1 , Enayat Kalantar 2 , Pegman Karami 1 , Mahnaz Sadeghi 3 , Shiva Ahdi Khosroshahi 4 and Safar Farajnia 5 , *
Authors Information
1 Department of Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, IR Iran
2 Department of Microbiology, School of Medicine, Alborz University of Medical Sciences, Alborz, IR Iran
3 Tuberculosis and Lung Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
4 Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
5 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
Article information
  • Jundishapur Journal of Microbiology: January 01, 2014, 7 (1); e8888
  • Published Online: January 1, 2014
  • Article Type: Research Article
  • Received: November 15, 2012
  • Revised: January 23, 2013
  • Accepted: March 14, 2013
  • DOI: 10.5812/jjm.8888

To Cite: Alikhani M Y, Karimi Tabar Z, Mihani F, Kalantar E, Karami P, et al. Antimicrobial Resistance Patterns and Prevalence of blaPER-1 and blaVEB-1 Genes Among ESBL-producing Pseudomonas aeruginosa Isolates in West of Iran, Jundishapur J Microbiol. 2014 ; 7(1):e8888. doi: 10.5812/jjm.8888.

Abstract
Copyright © 2014, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Pagani L, Mantengoli E, Migliavacca R, Nucleo E, Pollini S, Spalla M, et al. Multifocal detection of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase in Northern Italy. J Clin Microbiol. 2004; 42(6): 2523-9[DOI][PubMed]
  • 2. Isturiz RE, Carbon C. Antibiotic use in developing countries. Infect Control Hosp Epidemiol. 2000; 21(6): 394-7[DOI][PubMed]
  • 3. Livermore DM, Brown DF. Detection of beta-lactamase-mediated resistance. J Antimicrob Chemother. 2001; 48 Suppl 1: 59-64[PubMed]
  • 4. Ben-Mahrez Kamel, Rejiba Samia, Belhadj Cherifa, Belhadj Omrane. β-lactamase-mediated resistance to extended spectrum cephalosporins among clinical isolates of Pseudomonas aeruginosa. Res Microbiol. 1999; 150(6): 403-406[DOI]
  • 5. Lee S, Park YJ, Kim M, Lee HK, Han K, Kang CS, et al. Prevalence of Ambler class A and D beta-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea. J Antimicrob Chemother. 2005; 56(1): 122-7[DOI][PubMed]
  • 6. Poirel L, Lebessi E, Castro M, Fevre C, Foustoukou M, Nordmann P. Nosocomial outbreak of extended-spectrum beta-lactamase SHV-5-producing isolates of Pseudomonas aeruginosa in Athens, Greece. Antimicrob Agents Chemother. 2004; 48(6): 2277-9[DOI][PubMed]
  • 7. Weldhagen GF. Rapid detection and sequence-specific differentiation of extended-spectrum beta-lactamase GES-2 from Pseudomonas aeruginosa by use of a real-time PCR assay. Antimicrob Agents Chemother. 2004; 48(10): 4059-62[DOI][PubMed]
  • 8. Essack SY. Laboratory detection of extended-spectrum β-lactamases (ESBLs)—The need for a reliable, reproducible method. Diag Microbiol Infect Dis. 2000; 37(4): 293-295[DOI]
  • 9. Jacoby GA, Han P. Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol. 1996; 34(4): 908-11[PubMed]
  • 10. Poirel L, Menuteau O, Agoli N, Cattoen C, Nordmann P. Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol. 2003; 41(8): 3542-7[PubMed]
  • 11. Wolska MK, Bukowski K, Jakubczak A. [Occurrence of beta-lactamase type ESBL and IBL in Pseudomonas aeruginosa rods]. Med Dosw Mikrobiol. 2001; 53(1): 45-51[PubMed]
  • 12. Aubert D, Poirel L, Chevalier J, Leotard S, Pages JM, Nordmann P. Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2001; 45(6): 1615-20[DOI][PubMed]
  • 13. Endimiani A, Luzzaro F, Pini B, Amicosante G, Rossolini GM, Toniolo AQ. Pseudomonas aeruginosa bloodstream infections: risk factors and treatment outcome related to expression of the PER-1 extended-spectrum beta-lactamase. BMC Infect Dis. 2006; 6: 52[DOI][PubMed]
  • 14. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966; 45(4): 493-6[PubMed]
  • 15. Wayne PA. Performance standards for antimicrobial susceptibility testing. Ninth informational supplement NCCLS document M100-S9. National Committee for Clinical Laboratory Standards. 2008;
  • 16. Yousefi S, Farajnia S, Nahaei MR, Akhi MT, Ghotaslou R, Soroush MH, et al. Detection of metallo-beta-lactamase-encoding genes among clinical isolates of Pseudomonas aeruginosa in northwest of Iran. Diagn Microbiol Infect Dis. 2010; 68(3): 322-5[DOI][PubMed]
  • 17. Sohrabi N, Farajnia S, Akhi MT, Nahaei MR, Naghili B, Peymani A, et al. Prevalence of OXA-type beta-lactamases among Acinetobacter baumannii isolates from Northwest of Iran. Microb Drug Resist. 2012; 18(4): 385-9[DOI][PubMed]
  • 18. Todar Kenneth. Todar's online textbook of bacteriology. 2006;
  • 19. Hauser AR, Sriram P. Severe Pseudomonas aeruginosa infections. Tackling the conundrum of drug resistance. Postgrad Med. 2005; 117(1): 41-8[PubMed]
  • 20. Chayakulkeeree M, Junsriwong P, Keerasuntonpong A, Tribuddharat C, Thamlikitkul V. Epidemiology of extended-spectrum beta-lactamase producing gram-negative bacilli at Siriraj Hospital, Thailand, 2003. Southeast Asian J Trop Med Public Health. 2005; 36(6): 1503-9[PubMed]
  • 21. Kaushik Robin, Kumar Sandeep, Sharma Rajeev, Lal Pawanindra. Bacteriology of burn wounds — the first three years in a new burn unit at the Medical College Chandigarh. Burns. 2001; 27(6): 595-597[DOI]
  • 22. Mirsalehian A, Feizabadi M, Nakhjavani FA, Jabalameli F, Goli H, Kalantari N. Detection of VEB-1, OXA-10 and PER-1 genotypes in extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients. Burns. 2010; 36(1): 70-4[DOI][PubMed]
  • 23. Nikbin VS, Abdi-Ali A, Feizabadi MM, Gharavi S. Pulsed field gel electrophoresis & plasmid profile of Pseudomonas aeruginosa at two hospitals in Tehran, Iran. Indian J Med Res. 2007; 126(2): 146-51[PubMed]
  • 24. Ozumba UC, Jiburum BC. Bacteriology of burn wounds in Enugu, Nigeria. Burns. 2000; 26(2): 178-180[DOI]
  • 25. Celenza G, Pellegrini C, Caccamo M, Segatore B, Amicosante G, Perilli M. Spread of bla(CTX-M-type) and bla(PER-2) beta-lactamase genes in clinical isolates from Bolivian hospitals. J Antimicrob Chemother. 2006; 57(5): 975-8[DOI][PubMed]
  • 26. Chanawong A, M'Zali FH, Heritage J, Lulitanond A, Hawkey PM. SHV-12, SHV-5, SHV-2a and VEB-1 extended-spectrum beta-lactamases in Gram-negative bacteria isolated in a university hospital in Thailand. J Antimicrob Chemother. 2001; 48(6): 839-52[PubMed]
  • 27. Shahcheraghi F, Nikbin VS, Feizabadi MM. Prevalence of ESBLs genes among multidrug-resistant isolates of Pseudomonas aeruginosa isolated from patients in Tehran. Microb Drug Resist. 2009; 15(1): 37-9[DOI][PubMed]
  • 28. Tsakris A, Vatopoulos AC, Tzouvelekis LS, Legakis NJ. Diversity of resistance phenotypes and plasmid analysis in multi-resistant 0:12 Pseudomonas aeruginosa. Eur J Epidemiol. 1992; 8(6): 865-70[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments